| 名稱 | KMT2A-AFF1 Translocation |
| 型號(hào) | CBP20193D |
| 報(bào)價(jià) |  |
| 特點(diǎn) | KMT2A-AFF1 Translocation |
產(chǎn)品搜索
相關(guān)文章
- Cell Rep：發(fā)現(xiàn)治療乳腺癌轉(zhuǎn)移的重要新靶標(biāo)！
- 可視化觀察黑色素瘤早期轉(zhuǎn)移，鑒定出一種新的治療靶標(biāo)
- NGS檢測(cè)血液腫瘤基因
- PTPRZ1-MET腦膠質(zhì)瘤分子診斷標(biāo)準(zhǔn)品上新
- 腸道守護(hù)者--GLP2R
- 【靶點(diǎn)模型+診斷質(zhì)控】BTK C481S的藥物開發(fā)和診斷
- TLR激動(dòng)劑藥物細(xì)胞篩選模型
- 選擇性組蛋白去乙酰化酶抑制劑在腫瘤免疫治療中的作用及前景
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn)：ADORA2B（腺苷A2B受體）
- BRAF系列標(biāo)準(zhǔn)品
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Translocation > CBP20193DKMT2A-AFF1 Translocation
- 詳細(xì)內(nèi)容
CBP20193D | |
| Format | DNA |
| Description | KMT2A (Lysine Methyltransferase 2A) is a Protein Coding gene. Diseases associated with KMT2A include Wiedemann-Steiner Syndrome and Acute Myeloid Leukemia With T(9;11)(P22;Q23). Among its related pathways are Gene expression (Transcription) and RNA Polymerase I Promoter Opening. AFF1 (ALF Transcription Elongation Factor 1) is a Protein Coding gene. Diseases associated with AFF1 include B-Lymphoblastic Leukemia/Lymphoma With Recurrent Genetic Abnormality and Leukemia. |
| Technical Data | |
| Left Gene | KMT2A |
| Left Breakpoint | chr11:1183****5:+ （hg19） |
| Right Gene | AFF1 |
| Right Breakpoint | chr4:880****5:+ （hg19） |
| %AF | N/A |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)